Exam 3 Flashcards
medulla fxn
involuntary (autonomic fxn)
-breathing, cardiac, vasomotor response, reflexes (like coughing)
pons fxn
relays signal from forebrain to cerebellum
midbrain fxn
SN: delivers dopamine to striatum
-some voluntary movement control and some cognitive fxn
cerebellum fxn
motor coordination for smooth movements
cortex fxn
processing and interpreting information
thalamus fxn
relay signals to and from cortex
astrocytes role
-provide neurons with growth factors and antioxidants
-remove excess glutamate (excess glutamate can cause excitotoxicity that can cause harm to neurons, astrocytes regulate this)
-support BBB
oligodendrocytes role
-produce myelin sheath that insulates axons
microglia role
-provides growth factors
-clears debris by phagocytosis (similar to macrophages)
-can cause inflammatory response that may damage nearby neurons
GABA (aa) role in CNS disorders
-major inhibitory neurotransmitter in the brain (CNS depressants)
-lowers neuronal excitability by increasing Cl- ions into the neuron
glycine (aa) role in CNS disorders
similar to GABA but acts in the spinal cord
glutamate (aa) role in CNS disorders
-major excitatory aa neurotransmitter in the brain
-excess glutamate can lead to excess Ca2+ influx into the neuron, causing damage
do GABA and glutamate oppose each other or work together
sort of oppose each other (act as an on and off switch to regulate each other)
acetylcholine (non-aa)
-both muscarinic and nicotinic receptors
-drug include cholinesterase inhibitors like Aricept (for Alzheimer’s)
loss of dopamine signaling happens in what disease
PD
excessive dopamine signaling happens in what disease
schizophrenia
NET inhibitors treat what disease state
depression
Common sx of MS: just be familiar with these
-keep in mind no 2 MS patients will have the same Sx
visual problems
numbness/tingling
fatigue
difficulty walking/gait problems/falls/ataxia
pain
spasticity
stiffness
vertigo/dizziness
sexual dysfunction
bladder problems
constipation
depression or mood changes
MS drugs that only act in periphery (including BBB)
IFN beta
glatiramer acetate
natalizumab
mitoxantrone
teriflunomide
clabridine
rituximab (ocralizumab)
ATL1102 (ASO)